Dr. Hooshang Meshkinpour, MD

Dr. Meshkinpour practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Meshkinpour's NPI, 1053386243, was assigned on February 21, 2006. Dr. Meshkinpour graduated from Tehran University of Medical Sciences School of Medicine in 1965. Dr. Meshkinpour holds California license G25211.

Dr. Meshkinpour's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Meshkinpour's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Meshkinpour to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meshkinpour practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Meshkinpour's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Meshkinpour is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Meshkinpour's licenses on file in 3 states: California, Maryland and Pennsylvania.

Dmand AI lists acid reflux, chronic anemia, gastroduodenitis, gastroenteritis, gastrointestinal bleeding, hemorrhoids, intestinal diverticulosis and intestinal or bowel obstruction among the conditions Dr. Meshkinpour treats.

CMS data shows 444 Medicare services from Dr. Meshkinpour across 8 procedure codes in 2024, for 258 Medicare patients. Medicare paid $28,980 for them.

CMS counts 258 Medicare patients who saw Dr. Meshkinpour in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meshkinpour's median patient age at 60, with 62% women.

In 2024, Dr. Meshkinpour wrote 503 Medicare Part D claims for 154 patients. 90% of them were for generic drugs. CMS names the drug for 347 of them, across 5 drugs with 11 or more claims each, at $17,268 in total drug cost. In 2023, CMS named 382 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Meshkinpour for performance year 2024, reported through an alternative payment model (APM). Dr. Meshkinpour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meshkinpour as offering telehealth. CMS counts 29 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Meshkinpour, more than 55% of the clinicians it reports for that procedure.

Dmand AI links 59 papers to Dr. Meshkinpour. The most frequent topics are Colon, Evoked Potentials, Somatosensory and Adenoviridae Infections. Dr. Meshkinpour has published most often in Gastroenterology. Dr. Meshkinpour's most frequent co-authors are Scott Haldeman, MD, Nosratola D. Vaziri, MD and Narender Nath Bhatia, MD.

CMS Open Payments shows 5 general payments to Dr. Meshkinpour from 2 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 83% of the total. Medtronic, Inc. paid the most, $707.

Dmand AI lists 8 awards for Dr. Meshkinpour, most recently Best Doctor in 2018.

Dr. Meshkinpour graduated from Tehran University of Medical Sciences School of Medicine in 1965. Dr. Meshkinpour is a member of ACG and ACP.

Dr. Meshkinpour is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.